Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global 5-Hydroxytryptamine Receptor 2B Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 RP-5063
  • 1.3.3 INV-240
  • 1.3.4 DDD-024
  • 1.3.5 Others
• 1.4 Market Segment by Application
  • 1.4.1 Global 5-Hydroxytryptamine Receptor 2B Market Share by Application (2019-2025)
  • 1.4.2 Cirrhosis
  • 1.4.3 Liver Fibrosis
  • 1.4.4 Major Depressive Disorder
  • 1.4.5 Obesity
  • 1.4.6 Others
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global 5-Hydroxytryptamine Receptor 2B Market Size
  • 2.1.1 Global 5-Hydroxytryptamine Receptor 2B Revenue 2014-2025
  • 2.1.2 Global 5-Hydroxytryptamine Receptor 2B Sales 2014-2025
• 2.2 5-Hydroxytryptamine Receptor 2B Growth Rate by Regions
  • 2.2.1 Global 5-Hydroxytryptamine Receptor 2B Sales by Regions 2014-2019
  • 2.2.2 Global 5-Hydroxytryptamine Receptor 2B Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 5-Hydroxytryptamine Receptor 2B Sales by Manufacturers
  • 3.1.1 5-Hydroxytryptamine Receptor 2B Sales by Manufacturers 2014-2019
  • 3.1.2 5-Hydroxytryptamine Receptor 2B Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 5-Hydroxytryptamine Receptor 2B Revenue by Manufacturers (2014-2019)
  • 3.2.2 5-Hydroxytryptamine Receptor 2B Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global 5-Hydroxytryptamine Receptor 2B Market Concentration Ratio (CR5 and HHI)
• 3.3 5-Hydroxytryptamine Receptor 2B Price by Manufacturers
• 3.4 Key Manufacturers 5-Hydroxytryptamine Receptor 2B Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into 5-Hydroxytryptamine Receptor 2B Market
• 3.6 Key Manufacturers 5-Hydroxytryptamine Receptor 2B Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 RP-5063 Sales and Revenue (2014-2019)
  • 4.1.2 INV-240 Sales and Revenue (2014-2019)
  • 4.1.3 DDD-024 Sales and Revenue (2014-2019)
  • 4.1.4 Others Sales and Revenue (2014-2019)
• 4.2 Global 5-Hydroxytryptamine Receptor 2B Sales Market Share by Type
• 4.3 Global 5-Hydroxytryptamine Receptor 2B Revenue Market Share by Type
• 4.4 5-Hydroxytryptamine Receptor 2B Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global 5-Hydroxytryptamine Receptor 2B Sales by Application

6 United States

• 6.1 United States 5-Hydroxytryptamine Receptor 2B Breakdown Data by Company
• 6.2 United States 5-Hydroxytryptamine Receptor 2B Breakdown Data by Type
• 6.3 United States 5-Hydroxytryptamine Receptor 2B Breakdown Data by Application

7 European Union

• 7.1 European Union 5-Hydroxytryptamine Receptor 2B Breakdown Data by Company
• 7.2 European Union 5-Hydroxytryptamine Receptor 2B Breakdown Data by Type
• 7.3 European Union 5-Hydroxytryptamine Receptor 2B Breakdown Data by Application

8 China

• 8.1 China 5-Hydroxytryptamine Receptor 2B Breakdown Data by Company
• 8.2 China 5-Hydroxytryptamine Receptor 2B Breakdown Data by Type
• 8.3 China 5-Hydroxytryptamine Receptor 2B Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World 5-Hydroxytryptamine Receptor 2B Breakdown Data by Company
• 9.2 Rest of World 5-Hydroxytryptamine Receptor 2B Breakdown Data by Type
• 9.3 Rest of World 5-Hydroxytryptamine Receptor 2B Breakdown Data by Application
• 9.4 Rest of World 5-Hydroxytryptamine Receptor 2B Breakdown Data by Countries
  • 9.4.1 Rest of World 5-Hydroxytryptamine Receptor 2B Sales by Countries
  • 9.4.2 Rest of World 5-Hydroxytryptamine Receptor 2B Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 AnaMar AB
  • 10.1.1 AnaMar AB Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of 5-Hydroxytryptamine Receptor 2B
  • 10.1.4 5-Hydroxytryptamine Receptor 2B Product Introduction
  • 10.1.5 AnaMar AB Recent Development
• 10.2 Astellas Pharma Inc
  • 10.2.1 Astellas Pharma Inc Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of 5-Hydroxytryptamine Receptor 2B
  • 10.2.4 5-Hydroxytryptamine Receptor 2B Product Introduction
  • 10.2.5 Astellas Pharma Inc Recent Development
• 10.3 Biofrontera AG
  • 10.3.1 Biofrontera AG Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of 5-Hydroxytryptamine Receptor 2B
  • 10.3.4 5-Hydroxytryptamine Receptor 2B Product Introduction
  • 10.3.5 Biofrontera AG Recent Development
• 10.4 Neurim Pharmaceuticals Ltd
  • 10.4.1 Neurim Pharmaceuticals Ltd Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of 5-Hydroxytryptamine Receptor 2B
  • 10.4.4 5-Hydroxytryptamine Receptor 2B Product Introduction
  • 10.4.5 Neurim Pharmaceuticals Ltd Recent Development
• 10.5 RaQualia Pharma Inc
  • 10.5.1 RaQualia Pharma Inc Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of 5-Hydroxytryptamine Receptor 2B
  • 10.5.4 5-Hydroxytryptamine Receptor 2B Product Introduction
  • 10.5.5 RaQualia Pharma Inc Recent Development
• 10.6 Reviva Pharmaceuticals Inc
  • 10.6.1 Reviva Pharmaceuticals Inc Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of 5-Hydroxytryptamine Receptor 2B
  • 10.6.4 5-Hydroxytryptamine Receptor 2B Product Introduction
  • 10.6.5 Reviva Pharmaceuticals Inc Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 5-Hydroxytryptamine Receptor 2B Sales Channels
  • 11.2.2 5-Hydroxytryptamine Receptor 2B Distributors
• 11.3 5-Hydroxytryptamine Receptor 2B Customers

12 Market Forecast

• 12.1 Global 5-Hydroxytryptamine Receptor 2B Sales and Revenue Forecast 2019-2025
• 12.2 Global 5-Hydroxytryptamine Receptor 2B Sales Forecast by Type
• 12.3 Global 5-Hydroxytryptamine Receptor 2B Sales Forecast by Application
• 12.4 5-Hydroxytryptamine Receptor 2B Forecast by Regions
  • 12.4.1 Global 5-Hydroxytryptamine Receptor 2B Sales Forecast by Regions 2019-2025
  • 12.4.2 Global 5-Hydroxytryptamine Receptor 2B Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

In 2019, the market size of 5-Hydroxytryptamine Receptor 2B is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for 5-Hydroxytryptamine Receptor 2B.

This report studies the global market size of 5-Hydroxytryptamine Receptor 2B, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the 5-Hydroxytryptamine Receptor 2B sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
AnaMar AB
Astellas Pharma Inc
Biofrontera AG
Neurim Pharmaceuticals Ltd
RaQualia Pharma Inc
Reviva Pharmaceuticals Inc
...

Market Segment by Product Type
RP-5063
INV-240
DDD-024
Others

Market Segment by Application
Cirrhosis
Liver Fibrosis
Major Depressive Disorder
Obesity
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the 5-Hydroxytryptamine Receptor 2B status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key 5-Hydroxytryptamine Receptor 2B manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of 5-Hydroxytryptamine Receptor 2B are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025